Falls Church, Virginia. Sept. 19, 2012 – The American Thyroid Association (ATA) today announced it will honor Paul W. Ladenson, MD, of Johns Hopkins University in Baltimore, with the 2012 Lewis E. Braverman Award on Sept. 21 at the 82nd ATA Annual Meeting in Québec City, Québec, Canada. The Lewis E. Braverman Lectureship Award recognizes a member of the ATA who has demonstrated excellence and passion for mentoring fellows, students, and junior faculty and has a long history of productive thyroid research. The Lewis E. Braverman Award is endowed by contributions to honor Dr. Lewis E. Braverman.
Upon acceptance of the Award, Dr. Ladenson will deliver the 2012 Lewis E. Braverman Lecture entitled “Thyroid Hormone Analogues: Promise and Pitfall,” which will review the history of research to identify thyroid hormone-like compounds with targeted actions to treat diseases such as hypercholesterolemia and heart failure.
“While advancing his own body of research, Dr. Ladenson has become widely respected as one of endocrinology’s most thoughtful and trusted mentors, making him an outstanding choice for the 2012 Lewis E. Braverman Lectureship Award,” said ATA President James A. Fagin, MD, of Memorial Sloan-Kettering Cancer Center. “Countless fellows and trainees have benefited from the opportunity to work directly with Dr. Ladenson over the years and have gone on to assume leadership positions in the field of endocrinology at various universities, research institutes, and within the ATA.”
Dr. Ladenson holds several distinguished positions at Johns Hopkins University, where he is the John Eager Howard Professor of Endocrinology, and Professor of Medicine, Pathology, Oncology, Radiology and Radiological Science. He is also director of the Division of Endocrinology and Metabolism and a Distinguished University Professor.
Dr. Ladenson previously served as Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism. He is past president of the ATA, the Association of Program Directors in Endocrinology and Metabolism, and the Association of Subspecialty Professors. He attended Dartmouth College, Oxford University, and Harvard Medical School before training in Internal Medicine, and in Endocrinology and Metabolism at the Massachusetts General Hospital.
Dr. Ladenson’s research interests include applications of thyroid hormone analogues for treatment of cardiovascular disease, novel approaches to thyroid cancer diagnosis and management, and health economic analyses related to thyroid patient care. Currently, Dr. Ladenson is investigating effects of the nutritional supplement anatabine on autoimmune thyroiditis.
About the ATA Annual Meeting
The 82nd Annual Meeting of the American Thyroid Association will be held Sept. 19-23, in Québec City, Québec, Canada. This four-day creative and innovative scientific program, chaired by Elizabeth Pearce, MD, Boston Medical Center, and Douglas Forrest, PhD, National Institute of Diabetes and Digestive and Kidney Diseases, carefully balances clinical and basic science sessions on the latest advances in thyroidology. The ATA meeting is designed to offer continuing education for endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, endocrine fellows and nurses, physician assistants and other health care professionals. Visit www.thyroid.org for more information.
About the ATA
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. ATA is an international individual membership organization with over 1,600 members from 43 countries around the world. Celebrating its 89th anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, THYROID, Clinical Thyroidology and Clinical Thyroidology for Patients; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs through www.thyroid.org; and the development of guidelines for clinical management of thyroid disease. Visit www.thyroid.org for more information.
Executive Director of the American Thyroid Association
Phone: 703-772-2462 (texts preferred)